These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 20618775

  • 1. An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells.
    Boks MA, Zwaginga JJ, van Ham SM, ten Brinke A.
    Scand J Immunol; 2010 Aug; 72(2):158-68. PubMed ID: 20618775
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I, König B, Böttcher I, Knop J, Saloga J.
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro.
    George TC, Bilsborough J, Viney JL, Norment AM.
    Eur J Immunol; 2003 Feb; 33(2):502-11. PubMed ID: 12645949
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 11. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.
    Rutella S, Lemoli RM.
    Immunol Lett; 2004 Jun 15; 94(1-2):11-26. PubMed ID: 15234530
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 15; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 13. Generation of immune inhibitory dendritic cells and CD4+T regulatory cells inducing by TGF-beta.
    Abediankenari S, Ghasemi M.
    Iran J Allergy Asthma Immunol; 2009 Mar 15; 8(1):25-30. PubMed ID: 19279356
    [Abstract] [Full Text] [Related]

  • 14. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC.
    Boks MA, Kager-Groenland JR, Haasjes MS, Zwaginga JJ, van Ham SM, ten Brinke A.
    Clin Immunol; 2012 Mar 15; 142(3):332-42. PubMed ID: 22225835
    [Abstract] [Full Text] [Related]

  • 15. Vasoactive intestinal peptide: the dendritic cell --> regulatory T cell axis.
    Delgado M, Gonzalez-Rey E, Ganea D.
    Ann N Y Acad Sci; 2006 Jul 15; 1070():233-8. PubMed ID: 16888172
    [Abstract] [Full Text] [Related]

  • 16. The blind-spot of regulatory T cells.
    Graça L, Silva-Santos B, Coutinho A.
    Eur J Immunol; 2006 Apr 15; 36(4):802-5. PubMed ID: 16572390
    [Abstract] [Full Text] [Related]

  • 17. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.
    Torres-Aguilar H, Aguilar-Ruiz SR, González-Pérez G, Munguía R, Bajaña S, Meraz-Ríos MA, Sánchez-Torres C.
    J Immunol; 2010 Feb 15; 184(4):1765-75. PubMed ID: 20083662
    [Abstract] [Full Text] [Related]

  • 18. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 19. Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.
    Torres-Aguilar H, Blank M, Kivity S, Misgav M, Luboshitz J, Pierangeli SS, Shoenfeld Y.
    Ann Rheum Dis; 2012 Jan 15; 71(1):120-8. PubMed ID: 21914629
    [Abstract] [Full Text] [Related]

  • 20. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X, Li M, Lian D, Zheng X, Zhang ZX, Ichim TE, Xia X, Huang X, Vladau C, Suzuki M, Garcia B, Jevnikar AM, Min WP.
    Clin Immunol; 2008 Jun 15; 127(3):313-21. PubMed ID: 18358783
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.